|
|
||||||||
Ann Thorac Surg 1998;66:144-147
© 1998 The Society of Thoracic Surgeons
a Section of Cardiothoracic Surgery, William S. Middleton Memorial Veterans Hospital, University of Wisconsin School of Medicine, Madison, Wisconsin, USA
Accepted for publication March 4, 1998.
Address reprint requests to Dr Canver, Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine, H4/352, Clinical Science Center, 600 Highland Ave, Madison, WI 53792
e-mail: (cccanver{at}facstaff.wisc.edu)
| Abstract |
|---|
|
|
|---|
Methods. A retrospective chart review was performed on 939 patients who underwent primary coronary artery bypass grafting between July 1987 and November 1996. For better comparison, they were arbitrarily divided by age into two groups: group 1, less than 70 years old (n = 710), and group 2, 70 years old or older (n = 229). The variables collected for each patient included history of chronic obstructive pulmonary disease, active smoking, forced expiratory volume, and ventilatory support for more than 48 hours. These variables were compared with postoperative length of stay in the intensive care unit, length of stay in the hospital, and the midterm survival up to 5 years. The data were analyzed by the use of univariate/multivariate log-rank tests and the method of Kaplan-Meier survival estimates.
Results. The presence of chronic obstructive pulmonary disease was associated with increased length of stay in the intensive care unit and in the hospital for both groups. Preoperative forced expiratory volume in 1 second, significantly affected length of stay in the hospital only in the patients less than 70 years old (p = 0.0001). Delayed extubation beyond 48 hours of ventilatory support resulted in prolonged length of stay in the intensive care unit and in the hospital for patients less than 70 years old (p = 0.0001, p = 0.0001, respectively) and patients 70 years old or older (p = 0.0001, p = 0.0001, respectively). The 5-year survival after coronary artery bypass grafting for both groups was significantly influenced by the level of preoperative forced expiratory volume in 1 second (p = 0.0004, p = 0.0282, respectively).
Conclusions. Patients with chronic obstructive pulmonary disease, irrespective of age, stay in the intensive care unit and in the hospital longer after coronary artery bypass grafting. In addition, preoperative forced expiratory volume in 1 second is a significant predictor of 5-year survival in the young and aged individuals undergoing coronary artery bypass grafting.
| Introduction |
|---|
|
|
|---|
| Patients and methods |
|---|
|
|
|---|
For comparison purposes, patients were arbitrarily divided into two different age groups: group 1, included patients less than 70 years old (n = 710; range = 37 to 69 years), and group 2, included patients 70 years old or older (n = 229; range = 70 to 82 years). Most patients had class III or class IV angina according to the Canadian Cardiovascular Society. The indications for bypass grafting included unstable angina or angina after recent (<6 weeks) myocardial infarction. Most of the patients had three-vessel occlusive coronary disease at angiography. Most operations were performed by one of two cardiac surgeons (C.C.C. or G.M.K.). Cardiopulmonary bypass was established by the use of a membrane oxygenator. Cold blood cardioplegia was used predominantly.
The definitions of preoperative pulmonary variables were according to the protocol of the Department of Veterans Affairs Continuous Improvement in Cardiac Surgery [2]. The presence of COPD was recorded if the chart of the patient indicated COPD resulting in functional disability, hospitalization, required chronic bronchodilator therapy, FEV1 less than 75% of predicted value, or a combination of these factors. The patient was an active smoker if the patient or the chart indicated that the patient had smoked tobacco in any form (eg, cigarettes, pipe, or cigar) in the 2 weeks before the operation. The actual values for FEV1 were recorded from the most recent pulmonary function testing before the operation. The exact number of patients with various characteristics is shown in Table 1 for both groups.
|
Data are presented in the text and tables as simple percentage and frequency distributions. Statistical analysis was performed by the use of univariate or multivariate log-rank tests on SAS software program (SAS Inc, Cary, NC), and values were expressed as mean ± standard error of the mean. Patient survival estimates were calculated by actuarial analysis according to the method of Kaplan and Meier [5] and plotted at semiannual intervals using the day of CABG as the starting time. Significant differences were considered to exist when calculated p values were less than 0.05.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Comment |
|---|
|
|
|---|
Coronary bypass operation for ischemic heart disease is associated with significant risk of postoperative pulmonary complications. Although static pulmonary function tests have been used to assess the risk of respiratory complications after CABG, these tests have limited sensitivity and specificity [6]. Some patients estimated to be at high risk experience no difficulties, whereas others predicted to be at low risk, with only mild or moderate abnormalities of pulmonary function, have serious complications. Prior studies have reported conflicting results on the use of routine pulmonary function testing in an attempt to identify patients at higher risk for serious respiratory complciations after CABG [1, 79]. Recent emphasis on curbing the cost of a coronary bypass operation has led to selective use of preoperative screening pulmonary function testing at many hospitals. The Department of Veterans Affairs Continuous Improvement in Cardiac Surgery Study was initiated in 1987 to develop risk-adjusted outcome models of continuous quality improvement and to evaluate the efficacy of this approach on the quality of all cardiac surgical procedures performed in Veterans Administration medical centers [10]. Therefore, all patients in our study had routine screening preoperative pulmonary function testing because our Veterans Administration hospital was required to complete a single-page data form (73 patient-care variables) for each patient undergoing a cardiac operation [10].
Previous studies have not provided a definite clarification for the predictive value of preoperative FEV1 on patient survival after CABG. We found a relationship between preoperative level of FEV1 and reduced 5-year survival in patients undergoing CABG regardless of their age. We believe that the knowledge of a patients preoperative baseline pulmonary function might help to predict patients longevity after successful CABG.
Coronary bypass operation is not risk free for any age group. In our analysis, the perioperative mortality was comparable for the young and the elderly. However, it is necessary to reiterate that most patients in this analysis were veteran men with normal left ventricular function, and the results also pertain primarily to men. Conclusions of this study may not be completely applicable to women or to those individuals undergoing cardiac operations other than primary CABG.
With recognition of its retrospective nature, this study does not separate the patient groups according to other incremental risks, but affirms that impaired lung function before CABG is of predictive value irrespective of age. Performance of pulmonary function testing in patients with COPD before CABG is probably worthwhile. Such testing can be part of cost-effectiveness programs specifically dealing with patients who have impaired lung function, to minimize the expenditure for these patients in the health care delivery system.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. K. Stoller, E. Blackstone, G. Pettersson, and T. Mihaljevic Coronary Artery Bypass Graft and/or Valvular Operations Following Prior Pneumonectomy: Report of Four New Patients and Review of the Literature Chest, July 1, 2007; 132(1): 295 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Leavitt, C. S. Ross, B. Spence, S. D. Surgenor, E. M. Olmstead, R. A. Clough, D. C. Charlesworth, R. S. Kramer, G. T. O'Connor, and for the Northern New England Cardiovascular Diseas Long-Term Survival of Patients With Chronic Obstructive Pulmonary Disease Undergoing Coronary Artery Bypass Surgery Circulation, July 4, 2006; 114(1_suppl): I-430 - I-434. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Nakagawa, M. L. Franchini, P. Driusso, L. R. de Oliveira, P. H. N. Saldiva, and G. Lorenzi-Filho Mucociliary Clearance Is Impaired in Acutely Ill Patients Chest, October 1, 2005; 128(4): 2772 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. P. van Boven, W. B. M. Gerritsen, P. Zanen, J. C. Grutters, H. P. A. van Dongen, A. Bernard, and L. P. H. J. Aarts Pneumoproteins as a Lung-Specific Biomarker of Alveolar Permeability in Conventional On-pump Coronary Artery Bypass Graft Surgery vs Mini-Extracorporeal Circuit: A Pilot Study Chest, April 1, 2005; 127(4): 1190 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weissman Pulmonary Complications After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2004; 8(3): 185 - 211. [Abstract] [PDF] |
||||
![]() |
W J van Boven, W B Gerritsen, F G Waanders, F J Haas, and L P Aarts Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: A comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function Perfusion, July 1, 2004; 19(4): 239 - 246. [Abstract] [PDF] |
||||
![]() |
B. Medalion, M. G. Katz, A. J. Cohen, E. Hauptman, L. Sasson, and A. Schachner Long-term Beneficial Effect of Coronary Artery Bypass Grafting in Patients With COPD Chest, January 1, 2004; 125(1): 56 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Canver and J. Chanda Intraoperative and postoperative risk factors for respiratory failure after coronary bypass Ann. Thorac. Surg., March 1, 2003; 75(3): 853 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Frass, F. Buhling, M. Tager, H. Frass, S. Ansorge, C. Huth, and T. Welte Antioxidant and Antiprotease Status in Peripheral Blood and BAL Fluid After Cardiopulmonary Bypass Chest, November 1, 2001; 120(5): 1599 - 1608. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |